Global Prostate Cancer Diagnosis and Treatment Market Research Report 2024

Report ID: 1991683 | Published Date: Oct 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Prostate Specific Antigen Test (PSA)
        1.2.3 Digital Rectal Exam (DRE)
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic clinics
        1.3.4 Research centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2017-2028)
    2.2 Prostate Cancer Diagnosis and Treatment Growth Trends by Region
        2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Prostate Cancer Diagnosis and Treatment Market Dynamics
        2.3.1 Prostate Cancer Diagnosis and Treatment Industry Trends
        2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers
        2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges
        2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue
        3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2017-2022)
        3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
    3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
        3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2021
    3.5 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type
    4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application
    5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
    6.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
    7.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
    9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
        11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 AbbVie
        11.2.1 AbbVie Company Detail
        11.2.2 AbbVie Business Overview
        11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
        11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.2.5 AbbVie Recent Development
    11.3 Active Biotech
        11.3.1 Active Biotech Company Detail
        11.3.2 Active Biotech Business Overview
        11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
        11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.3.5 Active Biotech Recent Development
    11.4 Amgen
        11.4.1 Amgen Company Detail
        11.4.2 Amgen Business Overview
        11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
        11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.4.5 Amgen Recent Development
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Company Detail
        11.5.2 Astellas Pharma Business Overview
        11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
        11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.5.5 Astellas Pharma Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
        11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.6.5 AstraZeneca Recent Development
    11.7 Bavarian Nordic
        11.7.1 Bavarian Nordic Company Detail
        11.7.2 Bavarian Nordic Business Overview
        11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
        11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.7.5 Bavarian Nordic Recent Development
    11.8 Bayer
        11.8.1 Bayer Company Detail
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
        11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.8.5 Bayer Recent Development
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Detail
        11.9.2 Bristol-Myers Squibb Business Overview
        11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
        11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Recent Development
    11.10 Dendreon
        11.10.1 Dendreon Company Detail
        11.10.2 Dendreon Business Overview
        11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
        11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.10.5 Dendreon Recent Development
    11.11 Endo
        11.11.1 Endo Company Detail
        11.11.2 Endo Business Overview
        11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
        11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.11.5 Endo Recent Development
    11.12 Ferring Pharmaceuticals
        11.12.1 Ferring Pharmaceuticals Company Detail
        11.12.2 Ferring Pharmaceuticals Business Overview
        11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
        11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.12.5 Ferring Pharmaceuticals Recent Development
    11.13 GE Healthcare
        11.13.1 GE Healthcare Company Detail
        11.13.2 GE Healthcare Business Overview
        11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
        11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.13.5 GE Healthcare Recent Development
    11.14 GSK
        11.14.1 GSK Company Detail
        11.14.2 GSK Business Overview
        11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
        11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.14.5 GSK Recent Development
    11.15 Ipsen
        11.15.1 Ipsen Company Detail
        11.15.2 Ipsen Business Overview
        11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
        11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.15.5 Ipsen Recent Development
    11.16 Johnson & Johnson
        11.16.1 Johnson & Johnson Company Detail
        11.16.2 Johnson & Johnson Business Overview
        11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
        11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.16.5 Johnson & Johnson Recent Development
    11.17 Pfizer
        11.17.1 Pfizer Company Detail
        11.17.2 Pfizer Business Overview
        11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
        11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.17.5 Pfizer Recent Development
    11.18 Sanofi
        11.18.1 Sanofi Company Detail
        11.18.2 Sanofi Business Overview
        11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
        11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.18.5 Sanofi Recent Development
    11.19 Siemens Healthineers
        11.19.1 Siemens Healthineers Company Detail
        11.19.2 Siemens Healthineers Business Overview
        11.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
        11.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.19.5 Siemens Healthineers Recent Development
    11.20 Takeda
        11.20.1 Takeda Company Detail
        11.20.2 Takeda Business Overview
        11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
        11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.20.5 Takeda Recent Development
    11.21 Teva Pharmaceutical
        11.21.1 Teva Pharmaceutical Company Detail
        11.21.2 Teva Pharmaceutical Business Overview
        11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
        11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.21.5 Teva Pharmaceutical Recent Development
    11.22 Tolmar Pharmaceuticals
        11.22.1 Tolmar Pharmaceuticals Company Detail
        11.22.2 Tolmar Pharmaceuticals Business Overview
        11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
        11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
        11.22.5 Tolmar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Prostate Specific Antigen Test (PSA)
    Table 3. Key Players of Digital Rectal Exam (DRE)
    Table 4. Global Prostate Cancer Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Prostate Cancer Diagnosis and Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate Cancer Diagnosis and Treatment Market Share by Region (2017-2022)
    Table 8. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate Cancer Diagnosis and Treatment Market Share by Region (2023-2028)
    Table 10. Prostate Cancer Diagnosis and Treatment Market Trends
    Table 11. Prostate Cancer Diagnosis and Treatment Market Drivers
    Table 12. Prostate Cancer Diagnosis and Treatment Market Challenges
    Table 13. Prostate Cancer Diagnosis and Treatment Market Restraints
    Table 14. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate Cancer Diagnosis and Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2021)
    Table 17. Ranking of Global Top Prostate Cancer Diagnosis and Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
    Table 21. Date of Enter into Prostate Cancer Diagnosis and Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Laboratories Company Detail
    Table 42. Abbott Laboratories Business Overview
    Table 43. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product
    Table 44. Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 45. Abbott Laboratories Recent Development
    Table 46. AbbVie Company Detail
    Table 47. AbbVie Business Overview
    Table 48. AbbVie Prostate Cancer Diagnosis and Treatment Product
    Table 49. AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 50. AbbVie Recent Development
    Table 51. Active Biotech Company Detail
    Table 52. Active Biotech Business Overview
    Table 53. Active Biotech Prostate Cancer Diagnosis and Treatment Product
    Table 54. Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 55. Active Biotech Recent Development
    Table 56. Amgen Company Detail
    Table 57. Amgen Business Overview
    Table 58. Amgen Prostate Cancer Diagnosis and Treatment Product
    Table 59. Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 60. Amgen Recent Development
    Table 61. Astellas Pharma Company Detail
    Table 62. Astellas Pharma Business Overview
    Table 63. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product
    Table 64. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 65. Astellas Pharma Recent Development
    Table 66. AstraZeneca Company Detail
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Prostate Cancer Diagnosis and Treatment Product
    Table 69. AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 70. AstraZeneca Recent Development
    Table 71. Bavarian Nordic Company Detail
    Table 72. Bavarian Nordic Business Overview
    Table 73. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product
    Table 74. Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 75. Bavarian Nordic Recent Development
    Table 76. Bayer Company Detail
    Table 77. Bayer Business Overview
    Table 78. Bayer Prostate Cancer Diagnosis and Treatment Product
    Table 79. Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 80. Bayer Recent Development
    Table 81. Bristol-Myers Squibb Company Detail
    Table 82. Bristol-Myers Squibb Business Overview
    Table 83. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product
    Table 84. Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 85. Bristol-Myers Squibb Recent Development
    Table 86. Dendreon Company Detail
    Table 87. Dendreon Business Overview
    Table 88. Dendreon Prostate Cancer Diagnosis and Treatment Product
    Table 89. Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 90. Dendreon Recent Development
    Table 91. Endo Company Detail
    Table 92. Endo Business Overview
    Table 93. Endo Prostate Cancer Diagnosis and TreatmentProduct
    Table 94. Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 95. Endo Recent Development
    Table 96. Ferring Pharmaceuticals Company Detail
    Table 97. Ferring Pharmaceuticals Business Overview
    Table 98. Ferring Pharmaceuticals Prostate Cancer Diagnosis and TreatmentProduct
    Table 99. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 100. Ferring Pharmaceuticals Recent Development
    Table 101. GE Healthcare Company Detail
    Table 102. GE Healthcare Business Overview
    Table 103. GE Healthcare Prostate Cancer Diagnosis and TreatmentProduct
    Table 104. GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 105. GE Healthcare Recent Development
    Table 106. GSK Company Detail
    Table 107. GSK Business Overview
    Table 108. GSK Prostate Cancer Diagnosis and TreatmentProduct
    Table 109. GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 110. GSK Recent Development
    Table 111. Ipsen Company Detail
    Table 112. Ipsen Business Overview
    Table 113. Ipsen Prostate Cancer Diagnosis and TreatmentProduct
    Table 114. Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 115. Ipsen Recent Development
    Table 116. Johnson & Johnson Company Detail
    Table 117. Johnson & Johnson Business Overview
    Table 118. Johnson & Johnson Prostate Cancer Diagnosis and TreatmentProduct
    Table 119. Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 120. Johnson & Johnson Recent Development
    Table 121. Pfizer Company Detail
    Table 122. Pfizer Business Overview
    Table 123. Pfizer Prostate Cancer Diagnosis and TreatmentProduct
    Table 124. Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 125. Pfizer Recent Development
    Table 126. Sanofi Company Detail
    Table 127. Sanofi Business Overview
    Table 128. Sanofi Prostate Cancer Diagnosis and TreatmentProduct
    Table 129. Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 130. Sanofi Recent Development
    Table 131. Siemens Healthineers Company Detail
    Table 132. Siemens Healthineers Business Overview
    Table 133. Siemens Healthineers Prostate Cancer Diagnosis and TreatmentProduct
    Table 134. Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 135. Siemens Healthineers Recent Development
    Table 136. Takeda Company Detail
    Table 137. Takeda Business Overview
    Table 138. Takeda Prostate Cancer Diagnosis and TreatmentProduct
    Table 139. Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 140. Takeda Recent Development
    Table 141. Teva Pharmaceutical Company Detail
    Table 142. Teva Pharmaceutical Business Overview
    Table 143. Teva Pharmaceutical Prostate Cancer Diagnosis and TreatmentProduct
    Table 144. Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 145. Teva Pharmaceutical Recent Development
    Table 146. Tolmar Pharmaceuticals Company Detail
    Table 147. Tolmar Pharmaceuticals Business Overview
    Table 148. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and TreatmentProduct
    Table 149. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022) & (US$ Million)
    Table 150. Tolmar Pharmaceuticals Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Diagnosis and Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Prostate Specific Antigen Test (PSA) Features
    Figure 3. Digital Rectal Exam (DRE) Features
    Figure 4. Global Prostate Cancer Diagnosis and Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Diagnostic clinics Case Studies
    Figure 7. Research centers Case Studies
    Figure 8. Prostate Cancer Diagnosis and Treatment Report Years Considered
    Figure 9. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate Cancer Diagnosis and Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate Cancer Diagnosis and Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate Cancer Diagnosis and Treatment Market Share by Players in 2021
    Figure 13. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2021
    Figure 15. North America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Prostate Cancer Diagnosis and Treatment Market Share by Country (2017-2028)
    Figure 17. United States Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Prostate Cancer Diagnosis and Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Region (2017-2028)
    Figure 29. China Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 44. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 45. Active Biotech Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 46. Amgen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 47. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 48. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 49. Bavarian Nordic Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 50. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 52. Dendreon Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 53. Endo Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 54. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 55. GE Healthcare Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 56. GSK Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 57. Ipsen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 61. Siemens Healthineers Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 62. Takeda Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 63. Teva Pharmaceutical Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 64. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
AbbVie
Active Biotech
Amgen
Astellas Pharma
AstraZeneca
Bavarian Nordic
Bayer
Bristol-Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen
Johnson & Johnson
Pfizer
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals
Frequently Asked Questions
Prostate Cancer Diagnosis and Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Diagnosis and Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Diagnosis and Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rubber Tracks

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More